PEPG peer analysis
PepGen (PEPG) against its competitors: price, today's move, 1-year return and market value side by side.
PEPG and its peers
| Company | Price | Today | 1-year return | Market cap |
|---|---|---|---|---|
| ALEC Alector | $2.42 | -1.63% | 94.62% | $376.66M |
| CRBP Corbus | $3.60 | 2.27% | -64.51% | $71.66M |
| CRDF Cardiff Oncology | $0.80 | 0.68% | -64.65% | $61.87M |
| ELTX Elicio | $1.65 | 8.94% | -83.35% | $40.91M |
| FATE Fate Therapeutics | $1.75 | -9.79% | 90.38% | $240.71M |
| MOLN Molecular Partners | $3.21 | -0.98% | – | – |
| NKTX Nkarta | $1.45 | -8.81% | -23.10% | $108.51M |
| PEPG PepGen | $5.18 | 116.74% | -42.28% | $168.30M |
- PEPG's peers: ALEC (Alector), CRBP (Corbus), CRDF (Cardiff Oncology), ELTX (Elicio), FATE (Fate Therapeutics), MOLN (Molecular Partners), NKTX (Nkarta).
Updated 2026-11-10 16:50 UTC